Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Humanized SCID mouse models for biomedical research.

T Pearson1, D L Greiner, L D Shultz

  • 1Diabetes Division, University of Massachusetts Medical School, Worcester 01605, USA.

Current Topics in Microbiology and Immunology
|May 17, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a tumor-specific allo-HLA-restricted γδTCR.

Blood advances·2019
Same author

Humanized Mouse Models for Transplant Immunology.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG.

Oncogene·2015
Same author

A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.

Leukemia·2014
Same author

Extensive double humanization of both liver and hematopoiesis in FRGN mice.

Stem cell research·2014
Same author

Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.

Clinical and experimental immunology·2014
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Advancements in immunodeficient mouse models, including CB 17-scid, NOD-scid, and IL2rgamma(null) mice, have significantly improved in vivo studies of human hematopoiesis and immunity. These models are crucial for research without human subject risk.

Area of Science:

  • Immunology
  • Hematology
  • Animal Models

Background:

  • Effective animal models are essential for studying human hematopoiesis and immunity without risking human subjects.
  • Three major breakthroughs in small animal models for in vivo human hematopoiesis and immunity research have occurred over the last three decades.

Purpose of the Study:

  • To discuss the development and current state of immunodeficient mouse strains for human hematolymphoid cell engraftment.
  • To highlight the advancements from CB 17-scid to NOD-scid and IL2rgamma(null) mice.
  • To explore strategies for enhancing human hematolymphoid cell engraftment and function in NOD-scid IL2rgamma(null) mice.

Main Methods:

  • Review of key developments in immunodeficient mouse models: CB 17-scid (1983), NOD-scid (1995), and IL2rgamma(null) (2002-2005).

Related Experiment Videos

  • Comparison of engraftment capabilities of different mouse strains with human hematopoietic and lymphoid tissues.
  • Discussion of techniques used to improve engraftment in earlier models.

    • Main Results:

    • CB 17-scid mice enabled early SCID-Hu and Hu-PBL-SCID models.
    • NOD-scid mice showed enhanced engraftment compared to CB 17-scid mice, becoming a gold standard.
    • IL2rgamma(null) mice demonstrated significantly increased engraftment and function of human hematolymphoid cells compared to NOD-scid mice.

    Conclusions:

    • Immunodeficient IL2rgamma(null) mice represent a significant advancement for studying human hematopoiesis, immunity, and related diseases.
    • These models are vital for research in autoimmunity, infectious diseases, cancer biology, and regenerative medicine.
    • Further optimization of engraftment and function in NOD-scid IL2rgamma(null) mice is anticipated based on previous model enhancements.